Form 4 for AMLX Amylyx Pharmaceuticals, Inc.
Accepted 2025-05-27 00:00:00 ET · period of report 2025-05-22 · accession 0000950170-25-077677 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-05-27 | 2025-05-22 | AMLX | Mazzariello Gina | CLO | G - Gift | $0.00 | -1,000 | 187.0K | -0.5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-05-22 | G | D | 1,000 | $0.00 | 186,969 | D | — | — | (F1) Represents a bona fide gift for no consideration. |